•Blog
Enforcement Policy for Non-Invasive Remote Monitoring Devices Used To Support Patient Monitoring; Guidance for Industry and Food and Drug Administration Staff

FDA guidance context (November 18, 2026): This final FDA guidance was issued on October 19, 2023 and superseded the earlier COVID-19 public-health-emergency version. Its enforcement policy concerns certain limited modifications to specified legally marketed non-invasive remote monitoring devices; it is not blanket approval of all remote-monitoring products. See the official FDA guidance page for the authoritative scope. The original embedded document remains below, with a direct PDF link.
Move from information to action
See how the N9+ can fit your organization.
Explore the remote physical exam platform or request a focused demonstration.